The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

PDSB FINANCIAL STATEMENTS

PDS Biotechnology Corp — balance sheet, income statement and cash flow trends

PDSBPDS Biotechnology Corp

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-40 M-20 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue0 $Gross Profit-15.1 K $ · -Infinity%Operating Income-27.8 M $ · -Infinity%Pre-tax Income-33.7 M $ · -Infinity%Net Income to Owners-33.7 M $ · -Infinity%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue0 $-100.0%
Gross Profit-15.1 K $—
Operating Income-27.8 M $—
EBITDA-27.1 M $—
Net Income to Owners-33.7 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
025 M50 M75 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets8.8 M
  • Current Liabilities12.4 M $100%
  • Long-term Liabilities9.5 K $0%

Key Figures

YoY change
Total Assets8.8 M $-78.2%
Total Liabilities12.4 M $-49.5%
Total Equity-3.6 M $-122.4%
Cash & ST Investments5.6 M $-82.4%
Total Debt4.4 M $-76.5%
Net Debt-1.2 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-30 M-20 M-10 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-20 M-10 M0-16.8 M $Operating-9.5 M $Financing-26.3 M $Net Change

Key Figures

YoY change
Operating Cash Flow-16.8 M $—
Capital Expenditures13 $+160.0%
Free Cash Flow-16.8 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on PDSB

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.